Skip to content

Validation study about halitosis-reducing effects by long-term usage of zinc chloride-containing toothpaste and copper gluconate-containing mouth-rinse solution

Validation study about halitosis-reducing effects by long-term usage of zinc chloride-containing toothpaste and copper gluconate-containing mouth-rinse solution - Validation study about halitosis-reducing effects by long-term usage of zinc chloride-containing toothpaste and copper gluconate-containing mouth-rinse solution

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042257
Enrollment
30
Registered
2021-09-21
Start date
2020-09-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male adults

Interventions

Continuous application of the toothpaste to the subjects, three times a day (after every meal) for 4 weeks. Continuous application of the mouth-wash solution to the subjects, three times a day (after

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy male subjects ranging in age from 20 to 49 years old. (2) Subjects equipped with not less than 20 teeth, and without some kind of periodontal disease. (3) Subjects having mild-to-moderate gingivitis. (4) Subjects with bad breath at steady state. (5) Subjects having meals three times a day, and toothbrushing after each meal. (6) Subjects having not less than four teeth among measurable six teeth (FDI: 16, 21, 24, 36, 41, 44), or their alternatives (FDI: 17, 15, 11, 22, 25, 37, 35, 31, 42, 45). (7) Subjects who gave informed consent to take part in this trial after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: (1) At the screening test, subjects who were determined as a patient having some dental caries (over C3 level) and/or severe periodontal disease. (2) Subjects with medical treatment for diabetic, chronic kidney, digestive, lung or cancer diseases. (3) Subjects having need of some kind of scaling with oral surgery treatment and/or anesthesia. (4) Subjects with some kind of allergy. (5) Subjects equipped with removable denture. (6) Subjects with smoking habit. (7) Subjects who are now under the other clinical trials with some kind of medicine/food, or going to take part in those trials. (8) Subjects who have took in some kind of antibiotic and/or antibacterial agent, regularly or within the last month to the screening test. (9) All through this trial, subjects who have any difficulty in refraining from using some kind of mouth-rinse solution and/or interdental brush. (10) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Design outcomes

Primary

MeasureTime frame
Concentrations of volatile sulfur compounds, such as H2S, Me3SH and Me2S

Secondary

MeasureTime frame
1. Gingivitis index 2. Swelling 3. Reddening 4. Overall effectiveness 5. Tongue coating

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026